--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "BMC MAT Quick Start" developer_entity: "Boston Medical Center Corporation" bundle_id: "org.bmcobat.app" app_store_id: "1524468581" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-01-06" report_date: "2026-08-31" last_verified: "2026-08-31T00:00:00.000Z" report_version: "1.4.1" total_reviews: 41 overall_rating: 4.9 sentiment: "Excited" sentiment_score: 75 confidence: "medium" confidence_score: 0.6 top_praise_theme: "Medical professionals frequently recommend this resource to patients for managing buprenorphine and naltrexone treatment protocols" top_complaint_theme: "The clinical database lacks specific medication entries like buprenorphine and naloxone combinations, limiting its utility for some practitioners" review_sample_size: 5 total_review_count: 5 analyzed_review_count: 5 data_age_days: 45 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "excited sentiment", "mobile app", "app review", "app analysis", "healthcare", "social", "service"] canonical_url: "https://marlvel.ai/apps/bmc-mat-quick-start" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # BMC MAT Quick Start Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.87 · Sentiment Excited - **Recent focus**: The clinical database lacks specific medication entries like buprenorphine and naloxone combinations, limiting its utility for some practitioners (top complaint) · Medical professionals frequently recommend this resource to patients for managing buprenorphine and naltrexone treatment protocols (top praise) > **TL;DR:** BMC MAT Quick Start is a medical app by Boston Medical Center Corporation, rated 4.87/5 by 41 users, with Excited user sentiment (75/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** BMC MAT Quick Start maintains Excited user sentiment (4.87/5 from 41 reviews), with users consistently praising medical professionals frequently recommend this resource to patients for managing buprenorphine and naltrexone treatment protocols. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.87/5 (41 reviews) | | **User Mood** | Excited | | **Category** | Medical | | **Developer** | Boston Medical Center Corporation | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.6/1.0) | | **Data Age** | 45d | ## Metadata & Market Performance - **Publisher:** Boston Medical Center Corporation - **Category:** Medical - **Target Audience:** Healthcare and social service professionals managing patients with opioid or alcohol use disorders. - **Platforms:** iOS & Android - **Version Reviewed:** 1.4.1 - **Report Date:** 2026-08-31 - **Signal Count:** 5 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 1524468581 - **Bundle ID:** org.bmcobat.app - **Google Play ID:** org.bmcobat.app - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-31 ## Executive Snapshot **What it is:** BMC MAT Quick Start is a clinical decision support tool for healthcare providers, offering interactive treatment algorithms for opioid and alcohol use disorders on iOS and Android. **Why users hire it:** It removes the cognitive friction of navigating complex, multi-step clinical protocols during patient consultations by providing instant access to decision trees and diagnostic tools. ## App DNA (Features & Intent) - **[Differentiator] Clinical Decision Trees:** Interactive algorithms for buprenorphine and naltrexone initiation, including withdrawal management and pain protocols. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Clinical Tools:** Integrated diagnostic calculators including DSM-5 criteria, COWS, and AUDIT-C. - **[Differentiator] Secure Messaging:** Functionality to securely text message patient tools and initiation guides. * *User Intent:* Users need clear guidance to understand and adopt the product quickly. ## Market Position {#market-position} BMC MAT Quick Start maintains a 5.0 rating on iOS and 4.6 on Android, reflecting high utility among its professional user base. The 236-day update gap signals a shift toward maintenance, prioritizing stability over new feature expansion. ## Monetization Strategy - **Model:** Free - **Tiers:** Fully free access for healthcare providers - **Analysis:** The app functions as a free distribution channel for the developer's training and technical assistance services, prioritizing professional adoption over direct monetization. ## 🟢 User Sentiment (Medium Confidence: 5 of 5 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.87/5 - **Platform Split:** iOS 5.0/5 (28 ratings) | Android 4.6/5 (13 ratings) - **Overall Sentiment:** Excited ### Top Praises - **Medical professionals frequently recommend this resource to patients for managing buprenorphine and naltrexone treatment protocols** - **The interface provides a clear and efficient experience for users navigating complex clinical guidance on mobile** ### Top Complaints (Impact Areas) - **The clinical database lacks specific medication entries like buprenorphine and naloxone combinations, limiting its utility for some practitioners** ## SWOT Analysis {#swot} **Core Strengths:** - Interactive decision trees reduce clinical cognitive load - Secure messaging integrates patient tools into workflows **Growth Levers:** - Expanding medication database addresses primary user complaint ## What's New - **Latest (v1.4, 10 months ago):** Added clinical guidance for buprenorphine initiation, pain management, and extended-release injectables. Streamlined clinical decision trees and navigation design. ## App Momentum (Maintenance) {#momentum} - Maintenance phase, no updates 236 days. - Last major release January 2026. > **Cadence:** 2 total versions · 2 majors in last 6 months · 236 days since last update · 91 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} BMC MAT Quick Start is a medical app that is completely free. It holds a 4.87/5 rating from 41 reviews. > **Bottom Line:** BMC MAT Quick Start provides high-utility clinical guidance that integrates into provider workflows, but the current maintenance-mode cadence risks eroding its value as medical protocols evolve. **Best for:** Healthcare and social service professionals managing patients with opioid or alcohol use disorders. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Audit medication database for missing formulations because users cite this as a primary utility gap → increase practitioner retention ### Outlook: Stable The market for clinical decision support tools is shifting toward integrated, real-time data, placing pressure on static tools like BMC MAT Quick Start to maintain accuracy. The app's current stability is an asset for clinicians, but the lack of recent updates will eventually force a pivot or sunset as treatment protocols evolve. - 🔴 The 236-day update gap indicates a shift to maintenance mode, which risks the app falling behind evolving clinical standards for addiction treatment. - 🟢 High professional satisfaction with the existing decision trees suggests the core utility remains strong, provided the database is kept accurate. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.87/5 | | Total Reviews | 41 | | Sentiment | Excited (75/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **BMC MAT Quick Start** (this app) | 4.87/5 | Excited | Boston Medical Center Corporation | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Boston Medical Center Corporation - **Website:** [https://www.addictiontraining.org/](https://www.addictiontraining.org/) - **Social:** [YouTube](https://www.youtube.com/@graykentta) ## Data Sources & Links - **App Store ID:** 1524468581 - **Google Play ID:** org.bmcobat.app - **Dev Site:** [Official Website](https://www.addictiontraining.org/) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 5 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 45 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/bmc-mat-quick-start) Data licensed for AI Agent attribution under CC-BY-NC 4.0.